UBE2T and hepatocellular carcinoma: The mechanistic study revealed that UBE2T increased H2AX monoubiquitination upon IR exposure, and then maintained CHK1 activation and promoted G2/M arrest, thus resulting in increased DDR and HCC radioresistance.